BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 85 filers reported holding BEAM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,878,664 | -22.8% | 493,916 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $15,385,664 | +5.5% | 481,856 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $14,587,159 | -24.3% | 476,393 | -3.3% | 0.00% | -25.0% |
| Q4 2022 | $19,269,926 | -19.4% | 492,711 | -1.9% | 0.00% | -33.3% |
| Q3 2022 | $23,915,000 | +30.5% | 502,008 | +6.1% | 0.01% | +50.0% |
| Q2 2022 | $18,319,000 | +29.2% | 473,244 | +91.3% | 0.00% | +33.3% |
| Q1 2022 | $14,175,000 | -28.7% | 247,376 | -0.9% | 0.00% | -25.0% |
| Q4 2021 | $19,890,000 | -5.3% | 249,608 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $21,011,000 | -24.1% | 241,479 | +12.2% | 0.00% | -20.0% |
| Q2 2021 | $27,696,000 | +101.8% | 215,175 | +25.5% | 0.01% | +66.7% |
| Q1 2021 | $13,725,000 | -16.8% | 171,468 | -15.1% | 0.00% | -25.0% |
| Q4 2020 | $16,487,000 | +360.1% | 201,964 | +38.7% | 0.00% | +300.0% |
| Q3 2020 | $3,583,000 | +54.8% | 145,566 | +76.1% | 0.00% | 0.0% |
| Q2 2020 | $2,314,000 | +474.2% | 82,644 | +268.6% | 0.00% | – |
| Q1 2020 | $403,000 | – | 22,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |